Allosteric sensitization of proapoptotic BAX

Jonathan R Pritz1, Franziska Wachter1, Susan Lee1

  • 1Department of Pediatric Oncology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Insights

Researchers identified a novel compound that modulates BCL-2-associated X protein (BAX) activity. This discovery offers a new therapeutic strategy by lowering the apoptotic threshold, addressing challenges in BAX-targeted drug development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • BCL-2-associated X protein (BAX) is a key regulator of apoptosis.
  • BAX transitions from a cytosolic monomer to a mitochondrial oligomer.
  • Developing drugs targeting BAX is challenging due to its aggregation-prone nature.

Purpose of the Study:

  • To overcome challenges in screening BAX and identify modulators.
  • To understand the mechanism of BAX activation and oligomerization.
  • To explore therapeutic strategies for modulating BAX activity.

Main Methods:

  • Performed an NMR-based fragment screen of full-length human BAX.
  • Conducted biochemical and structural analyses of identified compounds.
  • Investigated the allosteric effects of the compound on BAX conformation.

Main Results:

  • Identified a compound that sensitizes BAX activation.
  • The compound binds to a pocket at the junction of α3-α4 and α5-α6 hairpins.
  • The compound allosterically mobilizes the α1-α2 loop and BAX BH3 helix, key to BAX activation and oligomerization.

Conclusions:

  • The identified compound reveals fundamental mechanisms of BAX conformational regulation.
  • The compound engages hydrophobic interactions preserving the inactive BAX state.
  • This provides a new opportunity to reduce the apoptotic threshold for therapeutic benefit.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.0K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.7K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.1K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.4K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.4K